Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.67) per share. This is a 5.7 percent decrease over losses of $(1.58) per share from the same period last year.
Rotor Acquisition Merger Partner Sarcos Defense Announces The Co. And BAE Systems Partner On A ~$1.7M Contract for Air Force Research Laboratory
Sarcos Defense, a wholly-owned subsidiary of Sarcos Robotics (“Sarcos”), a leader in the development of robots that augment humans to enhance productivity and safety, and global defense, aerospace, and
